Holen Sie sich die Stockscreener-App
7.87
0.13%
-0.010
Handel nachbörslich:
7.87
Schlusskurs vom Vortag:
$7.88
Offen:
$7.85
24-Stunden-Volumen:
6.35M
Relative Volume:
0.67
Marktkapitalisierung:
$5.37B
Einnahmen:
$6.55B
Nettoeinkommen (Verlust:
$-551.40M
KGV:
-9.7377
EPS:
-0.8082
Netto-Cashflow:
$438.90M
1W Leistung:
-0.88%
1M Leistung:
-7.74%
6M Leistung:
-31.68%
1J Leistung:
-37.29%
1-Tages-Spanne:
$7.69
$7.93
1-Wochen-Bereich:
$7.424
$8.015
52-Wochen-Spanne:
$7.265
$15.93
Avantor Inc Stock (AVTR) Company Profile
Firmenname
Avantor Inc
Sektor
Telefon
(610) 386-1700
Adresse
RADNOR CORPORATE CENTER, BUILDING ONE, RADNOR, PA
Compare AVTR vs ISRG, BDX, ALC, MDLN, RMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
AVTR
Avantor Inc
|
7.87 | 5.38B | 6.55B | -551.40M | 438.90M | -0.8082 |
ISRG
Intuitive Surgical Inc
|
439.80 | 159.03B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
146.25 | 40.49B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
67.93 | 32.81B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.10 | 30.65B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
208.98 | 30.44B | 5.54B | 1.52B | 1.74B | 10.37 |
Avantor Inc Stock (AVTR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-06 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2026-01-05 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2025-12-17 | Herabstufung | Jefferies | Hold → Underperform |
| 2025-12-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2025-11-04 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2025-10-30 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-10-30 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-08-01 | Herabstufung | Jefferies | Buy → Hold |
| 2025-04-29 | Herabstufung | Goldman | Buy → Neutral |
| 2025-04-28 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-04-28 | Herabstufung | Stifel | Buy → Hold |
| 2025-04-28 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-17 | Herabstufung | UBS | Buy → Neutral |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-07-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-01-04 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-12-11 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-09-28 | Eingeleitet | Bernstein | Mkt Perform |
| 2023-07-31 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2023-07-31 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2023-06-21 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Hold |
| 2022-10-05 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-09-14 | Herabstufung | Cowen | Outperform → Market Perform |
| 2022-09-09 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-04 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-30 | Fortgesetzt | Raymond James | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-08-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-06-04 | Eingeleitet | Goldman | Buy |
| 2021-04-29 | Hochstufung | Stifel | Hold → Buy |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-08-02 | Eingeleitet | Cleveland Research | Neutral |
| 2019-06-14 | Eingeleitet | Janney | Buy |
| 2019-06-12 | Eingeleitet | Raymond James | Outperform |
| 2019-06-11 | Eingeleitet | Goldman | Buy |
| 2019-06-11 | Eingeleitet | Guggenheim | Buy |
| 2019-06-11 | Eingeleitet | JP Morgan | Overweight |
| 2019-06-11 | Eingeleitet | Jefferies | Buy |
| 2019-06-11 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2019-06-11 | Eingeleitet | Piper Jaffray | Neutral |
| 2019-06-11 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2019-06-11 | Eingeleitet | Robert W. Baird | Outperform |
| 2019-06-11 | Eingeleitet | SunTrust | Buy |
| 2019-06-11 | Eingeleitet | UBS | Buy |
| 2019-06-11 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Avantor Inc Aktie (AVTR) Neueste Nachrichten
Avantor (AVTR): Buy, Sell, or Hold Post Q1 Earnings? - TradingView
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Avantor, Inc. (AVTR) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
Avantor’s SWOT analysis: life sciences stock faces mounting pressures By Investing.com - Investing.com Nigeria
Avantor appoints Gerard Porreca as quality and regulatory EVP - Investing.com UK
Global Cell Culture Media Market Outlook 2026-2036: Biologics Manufacturing and Cell Therapy Expansion Accelerate Growth for Avantor, Thermo Fisher Scientific, and Lonza Group AG - PR Newswire UK
Avantor appoints Gerard Porreca as quality and regulatory EVP By Investing.com - Investing.com Canada
Press Release: Avantor(R) Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory - Moomoo
Avantor’s SWOT analysis: life sciences stock faces mounting pressures - Investing.com
Avantor (AVTR) Fell as Destocking Has Lasted Longer Than Expected - Insider Monkey
Avantor (AVTR) Slid on Lower Than Expected Guidance - Insider Monkey
Avantor stock (US0543031027): focus shifts to margin recovery after Q1 earnings - AD HOC NEWS
Avantor, Inc. Common Stock (NY: AVTR - The Chronicle-Journal
Avantor's Turnaround Story Ongoing, Execution Risks Remain, RBC Says - marketscreener.com
RBC Capital assumes Avantor stock coverage with $9 target - Investing.com UK
RBC Capital assumes Avantor stock coverage with $9 target By Investing.com - Investing.com Nigeria
Avantor forecasts Q2 adjusted EPS of $0.19-$0.20 while incorporating $10M-$20M inflation headwind - MSN
Avantor Shareholders Approve Proposals at 2026 Annual Meeting - The Globe and Mail
Avantor (NYSE: AVTR) shareholders back board, pay plan and auditor in 2026 vote - Stock Titan
Avantor stock (US0543031027): Director Lucier buys $83,200 worth amid 31% yearly decline - AD HOC NEWS
Avantor director Gregory Lucier buys $83,200 in company stock - Investing.com India
Avantor director Gregory Lucier buys $83,200 in company stock By Investing.com - Investing.com Canada
Avantor (AVTR) director Mala Murthy granted 25,270 restricted stock units - Stock Titan
Avantor (NYSE: AVTR) director buys 10K shares and receives RSU grant - Stock Titan
Stock grant lifts Avantor (NYSE: AVTR) director Simon Dingemans’ holdings - Stock Titan
Avantor (AVTR) director Louise Makin receives 25,270-share restricted stock grant - Stock Titan
Avantor (AVTR) director Joseph Massaro granted 25,270 restricted stock units - Stock Titan
Avantor (AVTR) director awarded 25,270 RSUs vesting in May 2027 - Stock Titan
Avantor (AVTR) director receives 25,270-share equity grant, now holds 85,821 - Stock Titan
Avantor (AVTR) director Gregory Summe granted 25,270 RSUs, reports trust holdings - Stock Titan
The Technical Signals Behind (AVTR) That Institutions Follow - Stock Traders Daily
Flat Q1 Margins At Avantor (AVTR) Could Be A Game Changer For Its Efficiency Story - simplywall.st
Avantor shares jump 9% after Q1 earnings beat - MSN
Avantor expands Masterflex portfolio to streamline bioprocessing - MSN
Avantor (AVTR) Earnings Date and Reports 2026 $AVTR - MarketBeat
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Avantor, Inc. (AVTR) Investigation: Bronstein, Gewirtz & Grossman - The National Law Review
Avantor Reports Lower Q1 Profit, Reaffirms 2026 Guidance - MyChesCo
Avantor, Inc. $AVTR Shares Sold by Robeco Schweiz AG - MarketBeat
5 Must-Read Analyst Questions From Avantor’s Q1 Earnings Call - The Globe and Mail
Bronstein, Gewirtz & Grossman, LLC Encourages Avantor, Inc. (AVTR) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Avantor director Simon Dingemans buys $203,500 in company stock By Investing.com - Investing.com Nigeria
Avantor director Simon Dingemans buys $203,500 in company stock - Investing.com
Avantor (AVTR) director adds 25,000 shares via open-market purchase - Stock Titan
Avantor (NYSE: AVTR) EVP Ludovic Brellier awarded RSUs and 246,002 stock options - Stock Titan
Avantor (NYSE: AVTR) EVP files initial Form 3 ownership - Stock Titan
Finanzdaten der Avantor Inc-Aktie (AVTR)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.39%
0.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):